Evidence map›Paper›PMID 25773165›Full record

ArticleClinical and experimental medicine2016

Growth factors and IL-17 in hereditary angioedema.

M Salemi, V Mandalà, V Muggeo, G Misiano, S Milano, G Colonna-Romano, F Arcoleo, E Cillari

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Mast cell mediators in hereditary angioedema.Orphanet journal of rare diseases · 2026
    Article
  3. Review
  4. Article
  5. Roles of Immune Cells in Hereditary Angioedema.Clinical reviews in allergy & immunology · 2021
    Review
  6. Biomarkers in Hereditary Angioedema.Clinical reviews in allergy & immunology · 2021
    Review
  7. Article
  8. Article
  9. Genetics of Hereditary Angioedema Revisited.Clinical reviews in allergy & immunology · 2016
    Review
  10. "Nuts and Bolts" of Laboratory Evaluation of Angioedema.Clinical reviews in allergy & immunology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

M SalemiPatologia Clinica Presidio Ospedaliero V. Cervello, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
V MandalàDipartimento di Scienze Statistiche e Matematiche "Vianelli", Università di Palermo, Palermo, Italy.
V MuggeoDipartimento di Scienze Statistiche e Matematiche "Vianelli", Università di Palermo, Palermo, Italy.
G MisianoDipartimento di Biopatologia e Biotecnologie Mediche e Forensi (DiBiMeF), Via del Vespro 129, 90127, Palermo, Italy.
S MilanoDipartimento di Biopatologia e Biotecnologie Mediche e Forensi (DiBiMeF), Via del Vespro 129, 90127, Palermo, Italy.
G Colonna-RomanoDipartimento di Biopatologia e Biotecnologie Mediche e Forensi (DiBiMeF), Via del Vespro 129, 90127, Palermo, Italy.
F ArcoleoPatologia Clinica Presidio Ospedaliero V. Cervello, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
E CillariPatologia Clinica Presidio Ospedaliero V. Cervello, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy. enrico.cillari@tiscali.it.
Ospedale Vincenzo Cervello · ITUniversity of Palermo · ITPresidio Ospedaliero · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary angioedema (HAE) is a rare autosomal dominant disorder, due to C1-inhibitor deficiency, which causes episodic swellings of subcutaneous tissues, bowel walls and upper airways which are disabling and potentially life-threatening. We evaluated n = 17 patients with confirmed HAE diagnosis in basal and crisis state and n = 19 healthy subjects. The samples were tested for IL-17, FGFb, G-CSF and GM-CSF, using Bio-plex kit. Data analysis was performed via nonparametric Spearman's correlations and two sets of linear mixed models. When comparing HAE subjects during basal and crisis states, we found out significantly (i.e., p value <0.05) higher values in crisis states rather than in basal states for the three growth factors and cytokine IL-17. When comparing healthy subjects versus HAE patients at basal state, we found out significantly higher values in HAE subjects only for GM-CSF, FGFb and IL-17, but not for G-CSF. In HAE patients, there is a connection between IL-17 and growth factors. The low-grade inflammation in absence of attacks is demonstrated by constant higher amount of IL-17, FGFb and GM-CSF with respect to healthy patients. This could indicate that in this disease there is a level of activation that maintains the system in a "tick-over state," that can be activate by several stimuli that are able to induce a increase in inflammatory mediators during the acute attack.

Indexed as

AdolescentAdultAgedAngioedemas, HereditaryChildFemaleHumansIntercellular Signaling Peptides and ProteinsInterleukin-17MaleMiddle AgedYoung AdultIntercellular Signaling Peptides and ProteinsInterleukin-17Growth factorsHereditary angioedemaIL-17

Identifiers

PMID25773165
OpenAlexW2096432048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.